# NEOGENOMICS, INC. (NEO) FY2026 Q2 Balance Sheet

- Company: NEOGENOMICS, INC. (NEO)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-28, accession number 0001077183-26-000059
- Page: https://plicit.ai/financials/neo/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/neo-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 1,352,243,000 US dollars
- **Current assets**: 381,478,000 US dollars
- **Non-current assets**: 970,765,000 US dollars
- **Liabilities**: 566,511,000 US dollars
- **Current liabilities**: 105,883,000 US dollars
- **Non-current liabilities**: 460,628,000 US dollars
- **Equity**: 785,732,000 US dollars
- **Accounts receivable, net**: 175,405,000 US dollars
- **Cash and cash equivalents**: 145,539,000 US dollars
- **Inventories**: 27,137,000 US dollars
- **Prepaid assets**: 23,590,000 US dollars
- **Other current assets**: 9,807,000 US dollars
- **Goodwill**: 523,995,000 US dollars
- **Intangible assets, net**: 271,262,000 US dollars
- **Property and equipment (net of accumulated depreciation of $223,479 and $209,057, respectively)**: 80,938,000 US dollars
- **Operating lease right-of-use assets**: 78,606,000 US dollars
- **Other assets**: 9,311,000 US dollars
- **Financing lease right-of-use assets**: 6,653,000 US dollars
- **Accrued compensation**: 56,265,000 US dollars
- **Accrued expenses and other liabilities**: 23,045,000 US dollars
- **Accounts payable**: 20,953,000 US dollars
- **Current portion of operating lease liabilities**: 3,722,000 US dollars
- **Current portion of finance lease liabilities**: 1,704,000 US dollars
- **Contract liabilities**: 194,000 US dollars
- **Convertible senior notes, net (Note 6)**: 374,241,000 US dollars
- **Operating lease liabilities**: 64,671,000 US dollars
- **Deferred income tax liabilities, net**: 16,824,000 US dollars
- **Finance lease liabilities**: 4,030,000 US dollars
- **Other long-term liabilities**: 862,000 US dollars
- **Additional paid-in capital**: 1,259,272,000 US dollars
- **Common stock, $0.001 par value, (250,000,000 shares authorized; 130,301,168 and 128,989,152 shares issued, respectively; 127,917,946 and 128,989,152 shares outstanding, respectively)**: 130,000 US dollars
- **Accumulated other comprehensive income**: 4,000 US dollars
- **Accumulated deficit**: negative 448,674,000 US dollars
- **Treasury stock, at cost, (2,383,222 and 0 shares, respectively) (Note 7)**: negative 25,000,000 US dollars
- **Gross equity (calculated)**: 1,259,406,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.